Newstral
Article
The Globe and Mail on 2018-02-12 03:05
Purdue Pharma to stop marketing opioids to U.S. physicians, but policy not extended to Canada
Related news
- Purdue Pharma says it will stop promoting opioids to doctorsFOX 8 News Cleveland
- Sacklers Threaten to Pull Out of Purdue Pharma Opioids SettlementThe New York Times
- Purdue Pharma to stop promoting opioids to physicianswestfaironline.com
- Under seige for promoting opioids, Purdue Pharma now backs efforts to fight the epidemicLA Times
- Purdue Pharma pulls plug on marketing opioids in Canadawestfaironline.com
- NPurdue Pharma Offers $10-12B to Settle Opioid Claimsnecn.com
- Purdue Pharma to pay $18-million settlement to people addicted to OxyContin prescriptionsThe Globe and Mail
- Capping years of criticism, Purdue Pharma will stop promoting its opioid drugs to doctorsLA Times
- MN among 15 states in deal with Purdue Pharma, moving toward opioids settlementThe New York Times
- Purdue University: School has no connection to Purdue Pharmakentucky.com
- TOPINION: Purdue Pharma and the Opioid Epidemictheappalachianonline.com
- Florida among 6 states suing opioid maker Purdue Pharma; AG says opioids kill 15 a day in stateSun Sentinel
- Ontario judge puts settlement with Purdue Pharma on holdThe Globe and Mail
- OxyContin maker Purdue Pharma will stop promoting opioids to doctorscleveland.com
- Oklahoma to Announce Opioids Case Settlement With Purdue PharmaKTLA 5
- OxyContin maker Purdue Pharma to plead to 3 criminal chargesAlaska Dispatch News